PDS Biotechnology Corporation: PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors

Gross Proceeds of $11.3 Million at Initial Closing Transaction Led by Dr. Patrick Soon-Shiong, Founder of NantWorks PRINCETON, N.J., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (N ...
ABC4 Utah

New imaging and robotic technology at Intermountain Health is making treatment for prostate cancer easier and leading to faster recovery

Prostate cancer is the second leading cause of cancer deaths among men in the U.S. with more than 35,000 dying in 2025. It’s ...
Baptist Health South Florida

Grandfather and Avid Golfer Stays Active After Landmark Prostate Cancer Treatment at Baptist Health

At 76 years old, Pedro Lopez loves to play golf and keep a full schedule as a husband of 53 years, a father and a grandfather ...

PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors

Gross Proceeds of $11.3 Million at Initial Closing Transaction Led by Dr. Patrick Soon-Shiong, Founder of NantWorks PRINCETON, N.J., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation ...
VUMC News

Surgeons now using ‘pretzels’ to spare bladder for noninvasive bladder cancer patients

Pretzel-shaped devices containing new chemotherapies that release over time are giving bladder cancer patients a new ...
Targeted Oncology

AUA Annual Meeting

"This [TALAPRO-2] analysis represents the first...patient-level analysis to evaluate rPFS–OS correlation for a PARP inhibitor in first-line mCRPC," said Neeraj Agarwal, MD. “Combining [lutetium Lu 177 ...
urologytimes

Men's Health

Experts discuss the implications of the FDA’s potential pathway to expand testosterone replacement therapy labeling for low libido in men with idiopathic hypogonadism.